Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate -194.16% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -2.57
Flat results in Mar 26
Stock is technically in a Bearish range
Risky - Negative EBITDA
Below par performance in long term as well as near term
Stock DNA
Specialty Chemicals
INR 31 Cr (Micro Cap)
NA (Loss Making)
20
0.00%
-0.13
-18.42%
4.35
Total Returns (Price + Dividend) 
Latest dividend: 0.7 per share ex-dividend date: Feb-18-2020
Risk Adjusted Returns v/s 
Returns Beta
News

Daikaffil Chemicals India Ltd Falls to 52-Week Low of Rs 33 as Sell-Off Deepens
For the third consecutive session, Daikaffil Chemicals India Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 33 on 13 May 2026. This marks a steep drop of over 78% in the past year, sharply underperforming the broader Sensex, which has declined by just 8.13% over the same period.
Read More
Daikaffil Chemicals India Ltd is Rated Strong Sell
Daikaffil Chemicals India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 07 Apr 2025, reflecting a reassessment of the stock’s outlook. However, the analysis and financial metrics discussed here represent the company’s current position as of 17 April 2026, providing investors with the latest insights into its performance and prospects.
Read More Announcements 
Disclosures Under Reg. 29(2) Of SEBI (SAST) Regulations 2011
16-Jun-2026 | Source : BSEThe Company has received disclosure from Mikusu India Private Limited informing that it has acquired 5040 Equity shares of Daikaffil Chemicals India Limited from Open Market. Details of which are given in the file attached herewith.
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
16-Jun-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mikusu India Pvt Ltd
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
15-Jun-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mikusu India Pvt Ltd
Corporate Actions 
No Upcoming Board Meetings
Daikaffil Chemicals India Ltd has declared 7% dividend, ex-date: 18 Feb 20
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Mikusu India Private Limited (48.48%)
Mahendra Girdharilal (4.5%)
33.97%
Quarterly Results Snapshot (Standalone) - Dec'25 - YoY
YoY Growth in quarter ended Dec 2025 is -58.00% vs 0.00% in Dec 2024
YoY Growth in quarter ended Dec 2025 is 5.56% vs -28.57% in Dec 2024
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Growth in half year ended Sep 2025 is -3.41% vs -31.34% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 225.14% vs 0.00% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -0.81% vs -30.53% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
YoY Growth in year ended Mar 2025 is 16.32% vs 21.16% in Mar 2024